Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Endometrial receptivity characteristics in patients with repeated implantation failure: a study using LASSO regression and Bayesian generalized linear model analysis.

Frontiers in medicine·2026
Same author

Mechanisms and effects of ozone-pullulanase treatment on multiscale structures and in vitro digestibility of rice starch.

Food chemistry·2026
Same author

Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model.

Frontiers in pharmacology·2026
Same author

IL-4 peptide hydrogel reprograms MSC heterogeneity toward the CD106+ population for enhanced renal repair.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Pathological Structural Alterations of Serous Cell Cilia in the Parietal Pericardium of Patients With Heart Failure Induced by Dilated Cardiomyopathy.

Reviews in cardiovascular medicine·2026
Same author

Dynamic and Individualized Prediction of Acute Kidney Injury via Longitudinal Peripheral Blood Cell Trajectories among COVID-19 Inpatients: A Multicenter Prospective Cohort Study.

Kidney diseases (Basel, Switzerland)·2026

相关实验视频

Updated: Jun 3, 2026

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
10:18

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Published on: September 19, 2011

25.0K

心脏组织工程中的水凝:应用和挑战

Yaping Xu1, Yuexin Yu1, Zhikun Guo2,3

  • 1Henan Key Laboratory of Cardiac Remodeling and Transplantation, Zhengzhou Seventh People's Hospital, Henan, 450016, Zhengzhou, People's Republic of China.

Molecular and cellular biochemistry
|November 4, 2024
PubMed
概括
此摘要是机器生成的。

水凝为心脏组织工程提供了一个有前途的解决方案,支持受损的心脏组织并改善功能. 这种方法旨在克服目前用于心血管疾病的干细胞和移植疗法的局限性.

关键词:
心脏组织工程 心脏组织工程药物运输是药物交付的方式.心灵的心脏心脏的心脏心脏心脏水凝是一种水凝.干细胞是一种干细胞.

更多相关视频

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
08:41

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications

Published on: December 4, 2017

9.0K
Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

4.4K

相关实验视频

Last Updated: Jun 3, 2026

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
10:18

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Published on: September 19, 2011

25.0K
Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
08:41

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications

Published on: December 4, 2017

9.0K
Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

4.4K

科学领域:

  • 生物材料科学 生物材料科学
  • 再生医学是一种再生医学.
  • 心血管研究研究心血管研究

背景情况:

  • 心血管疾病是全球死亡的主要原因.
  • 目前的干细胞治疗和心脏移植等治疗方法在长期心脏功能稳定性方面存在局限性.
  • 心脏组织工程为心肌组织再生提供了一个潜在的策略.

研究的目的:

  • 审查水凝在心脏组织工程中的应用.
  • 探索在心脏修复中使用水凝的基础生物医学机制.
  • 讨论挑战,并提出基于水凝的心脏疗法的临床转化策略.

主要方法:

  • 在心脏组织工程中对水凝应用的文献综述.
  • 分析水凝的特性和作为支架和载体的功能.
  • 检查改善心肌收缩性和微环境的机制.

主要成果:

  • 水凝为心肌梗塞提供机械支持.
  • 水凝作为药物,生物活性因子和细胞的有效载体.
  • 水凝增强心肌收缩性,改善心脏细胞的微环境.

结论:

  • 水凝是心脏组织工程的一个可行的治疗选择.
  • 解决临床翻译挑战对于广泛采用至关重要.
  • 基于水凝的策略为治疗心血管疾病提供了新的途径.